Updated Fall 2023: Center for the Prevention of Progression (CPOP) is now Center for Early Detection and Interception of Blood Cancers.
In This Issue
- Early Detection and Prevention of Myeloid Malignancies in the Center for Prevention of Progression
- Clinical Trial Spotlight: Venetoclax plus Mini-hyper-CVD for ALL
- Telomere Biology Disorder Multidisciplinary Program
- NAVigating New Possibilities: Addition of Navitoclax to Ruxolitinib Shows Safety, Spleen Reduction, and Early Evidence of Fibrosis Reversal
- Faculty Spotlight: Q&A with Maximilian Stahl, MD
Hematologic Malignancies: Physician Resources
View our full list of hematologic malignancies resources for referring providers.